Brinker Capital Investments, LLC Natera, Inc. Transaction History

Brinker Capital Investments, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$86.26 - $119.0 $204,522 - $282,149	-2,371 Closed	0 $0
Q2 2021 Aug 03, 2021	SELL	$86.05 - $119.72 $482,654 - $671,509	-5,609 Reduced 70.29%	2,371 $269,000
Q1 2021 May 12, 2021	SELL	$91.47 - $124.36 $642,393 - $873,380	-7,023 Reduced 46.81%	7,980 $810,000
Q4 2020 Feb 16, 2021	BUY	$66.66 - $111.74 $608,405 - $1.02 Million	9,127 Added 155.33%	15,003 $1.49 Million
Q3 2020 Dec 03, 2020	BUY	$45.89 - $72.67 $269,649 - $427,008	5,876 New	5,876 $424,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

Stay updated on Brinker Capital Investments, LLC with notifications on news.